AR-639

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameAR-639
Drug Alias Nameoligonucleotides (Aronex)AR-639
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionVascular endothelial growth factor receptor antagonists
TargetsVascular endothelial growth factor receptor
Therapy Area/IndicationsCarcinoma, Renal CellCarcinoma, HepatocellularNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAronex Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAronex Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsCarcinoma, Renal CellCarcinoma, HepatocellularNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A